Gastroesophageal Reflux Disease Market - Top Companies and Manufacturers

Companies Dominating the Gastroesophageal Reflux Disease (GERD) Landscape

AstraZeneca PLC
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Eisai Co., Ltd.
GSK plc.
Takeda Pharmaceutical Company Limited.
Ironwood Pharmaceuticals, Inc.
Johnson & Johnson Services, Inc.
SFJ Pharmaceuticals
Sebela Pharmaceuticals
Phathom Pharmaceuticals, Inc.
Camber Pharmaceuticals, Inc.

Browse Key Market Insights with Data Illustration:

Gastroesophageal Reflux Disease (GERD) Market Size Forecasts 2037

In the News

AstraZeneca PLC has successfully signed the global license agreement with KYM Biosciences Inc. for the development of CMG901, an antibody-drug conjugate (ADC) targeting Claudin 18.2, a promising therapeutic target in gastric cancers.
Eisai Co., Ltd. and Bliss Biopharmaceutical Co., Ltd. have joined hands to develop BB-1701, an antibody-drug conjugate (ADC). This new drug is expected to have anti-tumor effects on breast, lung, and other solid tumors.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of gastroesophageal reflux disease is evaluated at USD 5.44 billion.

The gastroesophageal reflux disease market size was valued at USD 5.24 billion in 2024 and is set to exceed USD 7.13 billion by 2037, expanding at over 2.4% CAGR during the forecast period i.e., between 2025-2037. Higher consumption of processed food, increase in digestive issues, and problems caused by contaminated food will boost the market growth.

North America industry is predicted to dominate majority revenue share of 35% by 2037, owing to rising aging population in the region which are more prone to gastrointestinal problems.

The major players in the market are AstraZeneca PLC, Eisai Co., Ltd., GSK plc., Takeda Pharmaceutical Company Limited., Ironwood Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., SFJ Pharmaceuticals, Sebela Pharmaceuticals, Phathom Pharmaceuticals, Inc., Camber Pharmaceuticals, Inc.

Gastroesophageal Reflux Disease Market - Top Companies and Manufacturers

Companies Dominating the Gastroesophageal Reflux Disease (GERD) Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the gastroesophageal reflux disease market worth?

Why is the demand for gastroesophageal reflux disease growing?

Which region dominated the majority of gastroesophageal reflux disease industry share?

Who are the top gastroesophageal reflux disease companies?